Home Cart 0 Sign in  

[ CAS No. 90905-32-1 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 90905-32-1
Chemical Structure| 90905-32-1
Structure of 90905-32-1 * Storage: {[proInfo.prStorage]}

Please Login or Create an Account to: See VIP prices and availability

Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Search after Editing

* Storage: {[proInfo.prStorage]}

* Shipping: {[proInfo.prShipping]}

Quality Control of [ 90905-32-1 ]

Related Doc. of [ 90905-32-1 ]

Alternatived Products of [ 90905-32-1 ]
Product Citations

Product Details of [ 90905-32-1 ]

CAS No. :90905-32-1 MDL No. :MFCD03446732
Formula : C6H6N2O2 Boiling Point : -
Linear Structure Formula :- InChI Key :MERUNNHMVZFFRE-UHFFFAOYSA-N
M.W : 138.12 Pubchem ID :3151866
Synonyms :

Calculated chemistry of [ 90905-32-1 ]      Expand+

Physicochemical Properties

Num. heavy atoms : 10
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.17
Num. rotatable bonds : 2
Num. H-bond acceptors : 4.0
Num. H-bond donors : 0.0
Molar Refractivity : 33.91
TPSA : 52.08 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : No
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -7.16 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.19
Log Po/w (XLOGP3) : -0.03
Log Po/w (WLOGP) : 0.3
Log Po/w (MLOGP) : -0.88
Log Po/w (SILICOS-IT) : 1.01
Consensus Log Po/w : 0.32

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -0.99
Solubility : 14.2 mg/ml ; 0.102 mol/l
Class : Very soluble
Log S (Ali) : -0.61
Solubility : 33.6 mg/ml ; 0.243 mol/l
Class : Very soluble
Log S (SILICOS-IT) : -1.7
Solubility : 2.76 mg/ml ; 0.02 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 1.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.51

Safety of [ 90905-32-1 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 90905-32-1 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Downstream synthetic route of [ 90905-32-1 ]

[ 90905-32-1 ] Synthesis Path-Downstream   1~1

  • 1
  • [ 90905-32-1 ]
  • [ 34259-99-9 ]
  • (4-bromothiazol-2-yl)(2-methoxypyrimidin-5-yl)methanol [ No CAS ]
YieldReaction ConditionsOperation in experiment
32% To a stirred solution of <strong>[34259-99-9]<strong>[34259-99-9]4-bromothiazol</strong>e</strong> (50.0 mg, 0.3 05 mmol) in THF (2 mL) under nitrogen atmosphere was added n-butyllithium (2.5 molar solution in hexane) (0.183 mL, 0.45 7 mmol) at - 78 °C. Resulting pale yellow solution was stirred at -78 °C for 30 mm. Then, 2- methoxypyrimidine-5-carbaldehyde (37.9 mg, 0.274 mmol) in 0.5 mL THF was added and the reaction mixture was stirred at -78 °C for 1 h. Reaction was quenched with water (2 mL) anddiluted with ethyl acetate (5 mL). The organic layer was separated, washed with brine, dried over anhydrous sodium sulphate and evaporated under vacuum to get the crude product. The crude product was purified by combiflash chromatography (4 g Redisep® Si02 column, eluting with 72percent EtOAc in n-hexanes) to afford the title compound 143A (30 mg, 32percent) as a pale yellow oil. LC-MS retention time = 0.84 mm; m/z = 304.0 [M+Hf AQUITY UPLC BEH C18 (3.0 x 50mm)1.7 micron column; Mobile Phase A: 5 mM ammonium acetate in 95percent Water/ 5percent ACN; Mobile Phase B: 5 mM ammonium acetate in 5percent Water/ 95percent ACN; Gradient time 1.7 mm. 20percent B to 90percent B over 1.7 mm. Flow rate 0.7 mL/min; Detection: UV at 220 nm. 1H NMR (400 MHz, CD3OD) oe ppm 8.63 (s, 2H), 7.55 (s, 1H), 6.05 (s, 1H), 4.03 (s, 3H).
Recommend Products
Same Skeleton Products

Technical Information

Historical Records

Related Functional Groups of
[ 90905-32-1 ]

Aldehydes

Chemical Structure| 166757-62-6

[ 166757-62-6 ]

2-Hydroxypyrimidine-5-carbaldehyde

Similarity: 0.92

Chemical Structure| 52606-02-7

[ 52606-02-7 ]

2,4-Dimethoxypyrimidine-5-carbaldehyde

Similarity: 0.81

Chemical Structure| 10070-92-5

[ 10070-92-5 ]

Pyrimidine-5-carbaldehyde

Similarity: 0.77

Chemical Structure| 120747-84-4

[ 120747-84-4 ]

2-Aminopyrimidine-5-carbaldehyde

Similarity: 0.72

Chemical Structure| 1588441-19-3

[ 1588441-19-3 ]

2-Aminopyrimidine-5-carbaldehyde hydrate

Similarity: 0.72

Ethers

Chemical Structure| 52606-02-7

[ 52606-02-7 ]

2,4-Dimethoxypyrimidine-5-carbaldehyde

Similarity: 0.81

Chemical Structure| 944899-18-7

[ 944899-18-7 ]

(2-Methoxypyrimidin-5-yl)methanamine

Similarity: 0.80

Chemical Structure| 14001-60-6

[ 14001-60-6 ]

2-Methoxy-4-methylpyrimidine

Similarity: 0.75

Chemical Structure| 15400-58-5

[ 15400-58-5 ]

Methyl 2,4-dimethoxypyrimidine-5-carboxylate

Similarity: 0.73

Chemical Structure| 56621-89-7

[ 56621-89-7 ]

5-Amino-2-methoxypyrimidine

Similarity: 0.72

Related Parent Nucleus of
[ 90905-32-1 ]

Pyrimidines

Chemical Structure| 166757-62-6

[ 166757-62-6 ]

2-Hydroxypyrimidine-5-carbaldehyde

Similarity: 0.92

Chemical Structure| 52606-02-7

[ 52606-02-7 ]

2,4-Dimethoxypyrimidine-5-carbaldehyde

Similarity: 0.81

Chemical Structure| 38324-83-3

[ 38324-83-3 ]

2-Hydroxypyrimidine-5-carboxylic acid

Similarity: 0.80

Chemical Structure| 944899-18-7

[ 944899-18-7 ]

(2-Methoxypyrimidin-5-yl)methanamine

Similarity: 0.80

Chemical Structure| 10070-92-5

[ 10070-92-5 ]

Pyrimidine-5-carbaldehyde

Similarity: 0.77

; ;